Alan Boyd

Queen's University — Canada

Medicine · Health Sciences

38h-index4.2kcitations129works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(22), Neonatal Respiratory Health Research(19), Bacterial Genetics and Biotechnology(15), Virus-based gene therapy research(15), RNA and protein synthesis mechanisms(10)

Publications129 total

Short-Term Changes in Depressive Symptoms Among Patients with Alzheimer’s Disease Following a Precision Medicine Intervention
Brain Sciences·2025Open Access
Potential gene therapies for cystic fibrosis: a plain language summary for non-specialists and the lay community
Future Rare Diseases·2025
Kinome-Wide Screening Identifies FAK as a Novel Post-Translational Regulator of PD-L1 Stability and Immune Evasion in Triple-Negative Breast Cancer
International Journal of Molecular Sciences·2025Open Access
Significant Reduction in Depression Scores Following Implementation of the ReCODE Program: Evidence from PHQ-9 Assessments
Preprints.org·2025Open Access
Kinome-Wide Screening Identifies FAK as a Novel Post-Translational Regulator of PD-L1 Stability and Immune Evasion in Triple Negative Breast Cancer
Preprints.org·2025· 2 citedOpen Access
Abstract 3221: Identification and characterization of FAK kinase as a novel regulator of PD-L1 stability and activity in cancer immune evasion
Cancer Research·2025
Designing a precision-medicine platform trial to improve the nutritional care and intestinal health of very preterm babies: the COLLABORATE study
Efficacy and Mechanism Evaluation·2025Open Access
Cognitive and behavioral effects of perampanel 4 mg daily dose
Epilepsy & Behavior·2025· 2 cited
Leveraging Patient Advocacy and Faith-Based Partnerships to Educate, Activate, and Prepare Black Communities to Be Screened for Lung Cancer
CHEST Journal·2024· 1 cited
Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy
European Respiratory Journal·2024· 2 citedOpen Access
P045 Lenticlair™ 1: A phase 1/2 trial evaluating the safety, tolerability and efficacy of an inhaled F/HN-pseudotyped lentiviral vector for CF gene therapy in people with CF ineligible for CFTR modulators
Journal of Cystic Fibrosis·2024
P046 Lenticlair™-ON: An extension trial examining long-term safety and efficacy outcomes associated with an inhaled F/HN-pseudotyped lentiviral vector for CF gene therapy in people with cystic fibrosis
Journal of Cystic Fibrosis·2024
WS10.01 Administration of lentiviral vector doses achieving high transduction efficiency is well tolerated in mice
Journal of Cystic Fibrosis·2024
Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer’s Disease
Journal of Alzheimer s Disease·2023
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
Journal of Patient-Reported Outcomes·2023· 6 citedOpen Access
Precision Medicine Approach to Alzheimer’s Disease: Rationale and Implications
Journal of Alzheimer s Disease·2023· 8 citedOpen Access
WS17.06 F/HN pseudotyped lentiviral vector-mediated transduction of non-human primates
Journal of Cystic Fibrosis·2023· 1 citedOpen Access
Chimeric constructs confer the human CFTR chloride channel with the properties of mouse CFTR
Physiology·2023
Progress in Respiratory Gene Therapy
Human Gene Therapy·2022· 24 citedOpen Access
Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
Journal of Alzheimer s Disease·2022· 64 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

David J. Porteous(15), Eric W.F.W. Alton(12), J. Alastair Innes(11), Jane C. Davies(11), Stephen C. Hyde(10), Deborah R. Gill(10), Uta Griesenbach(10), Melvin I. Simon(6), Robert D. Gray(6), Gerry McLachlan(6), Tracy Higgins(6), A P Greening(5), Laura Hyndman(5), Ann Doherty(4), Ian A. Pringle(4), Stephanie Jones(4), David Collie(4), Heather Davidson(4), Stephen A. Boorjian(3), Neal D. Shore(3)